| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |